Clinical Trial Update: A Trial Of Azithromycin SR For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adults [Phase 3]

View source ↗

Summary

Phase 3 trial of Azithromycin SR for mild to moderate community-acquired pneumonia in Japanese adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Azithromycin SR (azithromycin)

Snippet

Sponsor: Pfizer | Conditions: Pneumonia, Community-Acquired | Phase 3 | Status: COMPLETED